Skip to main content

SIG BROKERAGE, LP

Broker-Dealer

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1094429 BALA CYNWYD, PA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
7 quarters on record

Derivatives in REGN

reported options exposure · as of Jun 30, 2026
CallValue
$8,729,560
CallShares
14,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SIG BROKERAGE, LP holds $14,503,065 across 7 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,729,560 14,000
2026-03-31 $772,640 1,000
2026-03-31 $11,589,600 15,000
2025-12-31 $10,806,180 14,000
2025-09-30 $7,871,780 14,000
2025-06-30 $7,350,000 14,000
2025-06-30 $2,992,500 5,700
2025-03-31 $8,879,220 14,000
2024-12-31 $757,919 1,064